TransMedics (TMDX) Cash from Investing Activities (2018 - 2026)

TransMedics' Cash from Investing Activities history runs 9 years deep, the most recent figure standing at -$36.7 million for Q1 2026.

• On a quarterly basis, Cash from Investing Activities fell 35.58% year-over-year to -$36.7 million in Q1 2026; TTM through Mar 2026 was -$68.9 million, a 38.6% increase from a year earlier, with the FY2025 full-year figure at -$59.3 million, up 54.18% from the prior year.
• Cash from Investing Activities retreated to -$36.7 million in Q1 2026 per TMDX's latest filing, from -$15.5 million in the prior quarter.
• Across five years, Cash from Investing Activities topped out at $24.7 million in Q3 2022 and bottomed at -$149.8 million in Q3 2023.
• The 5-year median for Cash from Investing Activities is -$13.6 million (2024), against an average of -$21.5 million.
• Across the five-year window, Cash from Investing Activities soared 478.73% in 2022 and tumbled 4665.05% in 2024, its largest moves.
• Year by year, Cash from Investing Activities stood at -$2.8 million in 2022, then sank by 1412.95% to -$41.8 million in 2023, then soared by 67.46% to -$13.6 million in 2024, then retreated by 14.02% to -$15.5 million in 2025, then slumped by 136.28% to -$36.7 million in 2026.
• Per Business Quant, the three latest TMDX Cash from Investing Activities figures stand at -$36.7 million (Q1 2026), -$15.5 million (Q4 2025), and -$7.6 million (Q3 2025).